Basic fibroblast growth factor: A potential therapeutic agent for the treatment of acute neurodegenerative disorders and vascular insufficiency

Expert Opinion on Therapeutic Patents

Volumn 8, Issue 11, 1998, Pages 1425-1445

  Moyer, J A ^a   Wood, A ^a   Zaleska, M M ^a   Ay, I ^a   Finklestein, S P ^a   Protter, A A ^a  

^a PFIZER INC   (United States)

Author keywords

Basic fibroblast growth factor; Brain trauma; Cell death; Claudication; Fiblast ; Fibroblast growth factor; Fibroblast growth factor 2; Ischaemia; Ischaemic heart disease; Leg ischaemia; Neurodegenerative disease; Neuroprotection; Spinal trauma; Stroke

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BASIC FIBROBLAST GROWTH FACTOR; EXCITATORY AMINO ACID; FREE RADICAL; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; HUMAN; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MITOCHONDRION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPINE INJURY; VASCULAR DISEASE;

EID: 0031795274     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.8.11.1425     Document Type: Review

References (142)